Overview

Randomized, Double-blind Study to Assess the Efficacy and Safety of α-lipoic Acid Versus BK-C-0701 in Subjects With Diabetic Neuropathy

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the: Primary end point - change of Total symptom score Secondary end point - neurological test
Phase:
Phase 3
Details
Lead Sponsor:
Bukwang Pharmaceutical
Treatments:
Thioctic Acid